Transcriptome-wide analysis of differential expression in perturbation atlases
- PMID: 40259084
- DOI: 10.1038/s41588-025-02169-3
Transcriptome-wide analysis of differential expression in perturbation atlases
Abstract
Single-cell CRISPR screens such as Perturb-seq enable transcriptomic profiling of genetic perturbations at scale. However, the data produced by these screens are noisy, and many effects may go undetected. Here we introduce transcriptome-wide analysis of differential expression (TRADE)-a statistical model for the distribution of true differential expression effects that accounts for estimation error appropriately. TRADE estimates the 'transcriptome-wide impact', which quantifies the total effect of a perturbation across the transcriptome. Analyzing several large Perturb-seq datasets, we show that many transcriptional effects remain undetected in standard analyses but emerge in aggregate using TRADE. A typical gene perturbation affects an estimated 45 genes, whereas a typical essential gene affects over 500. We find moderate consistency of perturbation effects across cell types, identify perturbations where transcriptional responses vary qualitatively across dosage levels and clarify the relationship between genetic and transcriptomic correlations across neuropsychiatric disorders.
© 2025. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Competing interests: J.S.W. declares outside interest in 5 AM Venture, Amgen, Chroma Medicine, KSQ Therapeutics, Maze Therapeutics, Tenaya Therapeutics, Tessera Therapeutics, Ziada Therapeutics and Third Rock Ventures. J.M.R. consults for Third Rock Ventures and Maze Therapeutics, and is a consultant for and equity holder in Waypoint Bio. The remaining authors declare no competing interests.
Update of
-
Transcriptome-wide characterization of genetic perturbations.bioRxiv [Preprint]. 2024 Jul 3:2024.07.03.601903. doi: 10.1101/2024.07.03.601903. bioRxiv. 2024. Update in: Nat Genet. 2025 May;57(5):1228-1237. doi: 10.1038/s41588-025-02169-3. PMID: 39005298 Free PMC article. Updated. Preprint.
References
MeSH terms
Grants and funding
- T32GM007753/U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
- T32GM007618/U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
- F31NS115380/U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
LinkOut - more resources
Full Text Sources
